Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Kumar, Pichumani"'
Autor:
Nourhan Abdelfattah, Parveen Kumar, Caiyi Wang, Jia-Shiun Leu, William F. Flynn, Ruli Gao, David S. Baskin, Kumar Pichumani, Omkar B. Ijare, Stephanie L. Wood, Suzanne Z. Powell, David L. Haviland, Brittany C. Parker Kerrigan, Frederick F. Lang, Sujit S. Prabhu, Kristin M. Huntoon, Wen Jiang, Betty Y. S. Kim, Joshy George, Kyuson Yun
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-18 (2022)
Glioblastoma (GBM) is an immune cold tumour that is refractory to immunotherapy. Here, the authors identify molecular phenotypes of immune-suppressive and -promoting myeloid cells in GBM through single cell RNA sequencing and propose S100A4 as a regu
Externí odkaz:
https://doaj.org/article/8729e15cfe464e098e0bc6e28aafb086
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Electromagnetic fields (EMF) raise intracellular levels of reactive oxygen species (ROS) that can be toxic to cancer cells. Because weak magnetic fields influence spin state pairing in redox-active radical electron pairs, we hypothesize that they dis
Externí odkaz:
https://doaj.org/article/94fb975157344b4393de38b79e10c8c6
Autor:
Wolfgang Bogner, Omkar B. Ijare, Martyn A. Sharpe, David S. Baskin, Santosh A. Helekar, Sophie Lopez, Fabio Henrique Brasil da Costa, Gilbert Hangel, Robert Bachoo, Shashank Hambarde, Kumar Pichumani, Georg Widhalm
Publikováno v:
Neuro Oncol
Background We postulate that meningiomas undergo distinct metabolic reprogramming in tumorigenesis and unraveling their metabolic phenotypes provide new therapeutic insights. Glutamine catabolism is key to the growth and proliferation of tumors. Here
Autor:
Omkar B. Ijare, Santosh A. Helekar, Martyn A. Sharpe, David S. Baskin, Kumar Pichumani, Shashank Hambarde
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 147:3577-3589
The mechanisms underlying anticancer effects of electromagnetic fields are poorly understood. An alternating electric field-generating therapeutic device called Optune™ device has been approved for the treatment of glioblastoma (GBM). We have devel
Autor:
Nourhan Abdelfattah, Parveen Kumar, Caiyi Wang, Jia-Shiun Leu, David Baskin, William Flynn, Ruli Gao, Kumar Pichumani, Omkar Ijare, Stephanie Wood, Suzanne Powell, David Haviland, Brittany Parker Kerrigan, Frederick Lang, Sujit Prabhu, Kristin Huntoon, Wen Jiang, Betty Kim, Joshy George, Kyuson Yun
Publikováno v:
Cancer Research. 83:5871-5871
With abundant pro-tumorigenic myeloid cells and few tumoricidal tumor-infiltrating lymphocytes ( Citation Format: Nourhan Abdelfattah, Parveen Kumar, Caiyi Wang, Jia-Shiun Leu, David Baskin, William Flynn, Ruli Gao, Kumar Pichumani, Omkar Ijare, Step
Autor:
Jonathan Hebert, Cole Holan, Kumar Pichumani, David S. Baskin, Martyn A. Sharpe, Omkar B. Ijare
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Scientific Reports
Scientific Reports
The diagnosis of various histological subtypes of pituitary tumors is made using serum based hormone panel test. However, certain subtypes secrete more than one hormone, making the diagnosis ambiguous. Here, we performed 1H-NMR based metabolomic anal
Publikováno v:
Neuro-Oncology. 24:vii268-vii268
Metabolic profiles of diffuse astrocytoma and recurrent tumor tissues were compared in a patient with diffuse astrocytoma who showed tumor recurrence and progressed to glioblastoma (GBM). The patient presented with a diffuse infiltrating tumor and wa
Publikováno v:
Neuro-Oncology. 24:vii262-vii262
Oxaloacetate (OAA) inhibits the Warburg effect by reducing the glucose-derived lactate levels in human cancer cell lines. In dose ranging IC50 experiments with human hepatocellular carcinoma (HCC) cell lines, OAA inhibited cell growth in the concentr
Autor:
Santosh A, Helekar, Shashank, Hambarde, Omkar B, Ijare, Kumar, Pichumani, David S, Baskin, Martyn A, Sharpe
Publikováno v:
Journal of cancer research and clinical oncology. 147(12)
The mechanisms underlying anticancer effects of electromagnetic fields are poorly understood. An alternating electric field-generating therapeutic device called Optune™ device has been approved for the treatment of glioblastoma (GBM). We have devel
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019)
Pituitary adenomas (PAs) are benign growths arising from epithelial cells in the adenohypophysis of the pituitary gland. To date, there has been no detailed metabolic characterization of PAs of various subtypes. In this study, we report nuclear magne